LLY vs VRA · P/E 39, rev $22.97B vs rev $84.9M
Eli Lilly and Company (LLY) versus Vera Bradley Inc (VRA) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Vera Bradley Inc (VRA) is a footwear & accessories company listed on NASDAQ.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported VRA revenue for 2026-01-31 was $84.9M. Net income was $2.7M. Revenue was down 77.2% from 2025-02-01 to 2026-01-31. VRA currently screens at market cap $107.2M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. VRA currently screens at market cap $107.2M.
Not investment advice. Open the LLY and VRA stock pages for the full models.
Not investment advice.